The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
The Nuclear Dot Protein Sp100, Characterization of Domains Necessary for Dimerization, Subcellular Localization, and Modification by Small Ubiquitin-like Modifiers
Open accessAbstract
The Sp100 and promyelocytic leukemia proteins (PML) are constituents of nuclear domains, known as nuclear dots (NDs) or PML bodies, and are both covalently modified by the small ubiquitin-related protein SUMO-1. NDs play a role in autoimmunity, virus infections, and in the etiology of acute promyelocytic leukemia. To date, little is known about the function of the Sp100 protein. Here we analyzed Sp100 domains that determine its subcellular localization, dimerization, and SUMOylation. A functional nuclear localization signal and an ND-targeting region that coincides with an Sp100 homodimerization domain were mapped. Sequences similar to the Sp100 homodimerization/ND-targeting region occur in several other proteins and constitute a novel protein motif, termed HSR domain. The lysine residue of the Sp100 protein, to which SUMO-1 is covalently linked, was mapped within and may therefore modulate the previously described HP1 protein-binding site. A consensus sequence for SUMOylation of proteins in general is suggested. SUMOylation strictly depended on a functional nuclear localization signal but was not necessary for nuclear import or ND targeting. A three-dimensional structure of Sp100, which supports the mapping data and provides additional information on Sp100 structure/function relationships, was generated by computer modeling. Taken together, our studies indicate the existence of well defined Sp100 domains with functions in ND targeting, nuclear import, nuclear SUMOylation, and protein-protein interaction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355
Aaltonen, J., Björses, P., Perheentupa, J., Horelli–Kuitunen, N., Palotie, A., Peltonen, L., Lee, Y. S., Francis, F., Henning, S., Thiel, C., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-399 · Cited by 1,228
Matunis, M. J., Coutavas, E., & Blobel, G. (1996) · The Journal of cell biology · doi:10.1083/jcb.135.6.1457 · Cited by 1,197
SUMO-1 Modification of IκBα Inhibits NF-κB Activation
Desterro, J. M. P., Rodriguez, M. S., & Hay, R. T. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80133-1 · Cited by 1,038
Structure and Function in the Nucleus
Lamond, A. I., & Earnshaw, W. C. (1998) · Science · doi:10.1126/science.280.5363.547 · Cited by 923
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Muller, S. (1998) · The EMBO Journal · doi:10.1093/emboj/17.1.61 · Cited by 674
A versatile in vivo and in vitro eukaryotic expression vector for protein engineering
Green, S., Issemann, I., & Sheer, E. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.1.369 · Cited by 666
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Johnson, E. S. (1997) · The EMBO Journal · doi:10.1093/emboj/16.18.5509 · Cited by 553
The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion.
Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L., Szostecki, C., Calvo, F., & Chomienne, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06356.x · Cited by 499
Matunis, M. J., Wu, J., & Blobel, G. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.3.499 · Cited by 464
Structure determination of the small ubiquitin-related modifier SUMO-1
Bayer, P., Arndt, A., Metzger, S., Mahajan, R., Melchior, F., Jaenicke, R., & Becker, J. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1839 · Cited by 445
A PMLRAR α transgene initiates murine acute promyelocytic leukemia
Brown, D., Kogan, S., Lagasse, E., Weissman, I., Alcalay, M., Pelicci, P. G., Atwater, S., & Bishop, J. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2551 · Cited by 434
Arenzana-Seisdedos, F., Thompson, J., Rodriguez, M. S., Bachelerie, F., Thomas, D., & Hay, R. T. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2689 · Cited by 433
Everett, R. D., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M., & Parkinson, J. (1998) · Journal of Virology · doi:10.1128/jvi.72.8.6581-6591.1998 · Cited by 402
SZOSTECKI, C., WILL, H., NETTER, H. J., & GULDNER, H. H. (1992) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1992.tb03224.x · Cited by 364
Self-citationBoddy, M. N., Howe, K. M., Etkin, L. D., Solomon, E., & Freemont, P. S. (1996) · PubMed · Cited by 348
Acute leukemia with promyelocytic features in PML/RARα transgenic mice
He, L.-Z., Tribioli, C., Rivi, R., Peruzzi, D., Pelicci, P. G., Soares, V., Cattoretti, G., & Pandolfi, P. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5302 · Cited by 339
Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., Chang, H. M., & Yeh, E. T. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.10.4277 · Cited by 335
Sternsdorf, T., Jensen, K., & Will, H. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.7.1621 · Cited by 331
Self-citationMaul, G. G., Guldner, H. H., & Spivack, J. G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-12-2679 · Cited by 315
Identification of Three Major Sentrinization Sites in PML
Kamitani, T., Kito, K., Nguyen, H. P., Wada, H., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.41.26675 · Cited by 310
Mahajan, R., Gerace, L., & Melchior, F. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.259 · Cited by 289
PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., & Chang, K. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6858 · Cited by 288
Identification of a novel nuclear domain.
Ascoli, C. A., & Maul, G. G. (1991) · The Journal of cell biology · doi:10.1083/jcb.112.5.785 · Cited by 285
Seeler, J.-S., Marchio, A., Sitterlin, D., Transy, C., & Dejean, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7316 · Cited by 274
Szostecki, C., Guldner, H. H., Netter, H. J., & Will, H. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.12.4338 · Cited by 269
Self-citationTargeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.
Carvalho, T., Seeler, J. S., Ohman, K., Jordan, P., Pettersson, U., Akusjärvi, G., Carmo-Fonseca, M., & Dejean, A. (1995) · The Journal of cell biology · doi:10.1083/jcb.131.1.45 · Cited by 269
A monoclonal antibody recognizing nuclear matrix-associated nuclear bodies
Stuurman, N., Graaf, A. D., Floore, A., Josso, A., Humbel, B., Jong, L. D., & Driel, R. V. (1992) · Journal of Cell Science · doi:10.1242/jcs.101.4.773 · Cited by 256
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
Localization of nascent RNA and CREB binding protein with the PML-containing nuclear body
LaMorte, V. J., Dyck, J. A., Ochs, R. L., & Evans, R. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.4991 · Cited by 239
The PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231
The acute promyelocytic leukaemia-associated PML gene is induced by interferon.
Lavau, C., Marchio, A., Fagioli, M., Jansen, J. H., Falini, B., Lebon, P., Grosveld, F. G., Pandolfi, P. P., Pelicci, P. G., & Dejean, A. (1995) · PubMed · Cited by 228
Covalent Modification of PML by the Sentrin Family of Ubiquitin-like Proteins
Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitani, T., & Yeh, E. T. H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3117 · Cited by 207
Day, P. M., Roden, R. B. S., Lowy, D. R., & Schiller, J. T. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.142-150.1998 · Cited by 205
Ubc9p and the conjugation of SUMO-1 to RanGAP1 and RanBP2
Saitoh, H., Sparrow, D. B., Shiomi, T., Pu, R. T., Nishimoto, T., Mohun, T. J., & Dasso, M. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70044-2 · Cited by 193
Chromatin components as part of a putative transcriptional repressing complex
Lehming, N., Le Saux, A., Schüller, J., & Ptashne, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7322 · Cited by 175
Nuclear bodies (NBs): A newly “rediscovered” organelle
Brasch, K., & Ochs, R. L. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90068-j · Cited by 171
Borden, K. L. B., Campbell Dwyer, E. J., & Salvato, M. S. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.758-766.1998 · Cited by 165
Gibson, T. J., Ramu, C., Gemünd, C., & Aasland, R. (1998) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01231-6 · Cited by 158
IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis
Guldner, H. H., Szostecki, C., Grötzinger, T., & Will, H. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.149.12.4067 · Cited by 156
Self-citationExclusion of Int-6 from PML Nuclear Bodies by Binding to the HTLV-I Tax Oncoprotein
Morris, C., Rousset, R., Bantignies, F., & Jalinot, P. (1996) · Science · doi:10.1126/science.273.5277.951 · Cited by 145
SUMO-1: wrestling with a new ubiquitin-related modifier
Saitoh, H., Pu, R. T., & Dasso, M. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01102-x · Cited by 144
Nuclear dots: Actors on Many Stages
Sternsdorf, T., Grötzinger, T., Jensen, K., & Will, H. (1997) · Immunobiology · doi:10.1016/s0171-2985(97)80051-4 · Cited by 143
Self-citationAnalysis of the Growth and Transformation Suppressor Domains of Promyelocytic Leukemia Gene, PML
Le, X., Yang, P., & Chang, K.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.1.130 · Cited by 126
Sternsdorf, T., Guldner, H. H., Szostecki, C., Grötzinger, T., & Will, H. (1995) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1995.tb03652.x · Cited by 125
Self-citationDiversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.
Bernstein, R. M., Neuberger, J., Bunn, C., Callender, M. E., Hughes, G. R. V., & Williams, R. L. (1984) · PubMed Central · Cited by 110
Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100).
Szostecki, C., Krippner, H., Penner, E., & Bautz, F. A. (1987) · PubMed Central · Cited by 106
Identification and Characterization of a Leukocyte-specific Component of the Nuclear Body
Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A., & Bloch, K. D. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29198 · Cited by 103
Nuclear Dot Antigens may Specify Transcriptional Domains in the Nucleus
Xie, K., Lambie, E. J., & Snyder, M. P. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.10.6170-6179.1993 · Cited by 88
Guldner, H. H., Szostecki, C., Schröder, P., Matschl, U., Jensen, K., Lueders, C., Will, H., & Sternsdorf, T. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.5.733 · Cited by 59
Self-citationMolecular cloning of two new interferon-induced, highly related nuclear phosphoproteins.
Kadereit, S., Gewert, D. R., GALABRU, J., Hovanessian, A. G., & MEURS, E. F. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80544-4 · Cited by 51
ANTINUCLEAR ANTIBODIES IN PRIMARY BILIARY CIRRHOSIS
Powell, F. C., Schroeter, A. L., & Dickson, E. R. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90164-8 · Cited by 50
Lang, C., Paulin‐Levasseur, M., Gajewski, A., Alsheimer, M., Benavente, R., & Krohne, G. (1999) · Journal of Cell Science · doi:10.1242/jcs.112.5.749 · Cited by 39
Ahn, M.-J., Nason-Burchenal, K., Moasser, M. M., & Dmitrovsky, E. (1995) · PubMed · Cited by 35
Grötzinger, T., Jensen, K., Guldner, H. H., Sternsdorf, T., Szostecki, C., Schwab, M., Savelyeva, L., Reich, B., & Will, H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.1150 · Cited by 23
Self-citation
Cited by
Concepts in sumoylation: a decade on
Geiss-Friedlander, R., & Melchior, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2293 · Cited by 1,785
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
Sumoylation: A Regulatory Protein Modification in Health and Disease
Flotho, A., & Melchior, F. (2013) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061909-093311 · Cited by 1,097
The Nucleoporin RanBP2 Has SUMO1 E3 Ligase Activity
Pichler, A., Gast, A., Seeler, J. S., Dejean, A., & Melchior, F. (2002) · Cell · doi:10.1016/s0092-8674(01)00633-x · Cited by 816
Melchior, F. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.591 · Cited by 774
Metadata
- Authors
- Sternsdorf, T., Jensen, K., Reich, B., & Will, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-04
- Volume
- 274
- Issue
- 18
- Pages
- 12555-12566
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1988841577
- Cited by
- 264
- References
- 58
- FWCI
- 7.61
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.